Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × AP 1903 reagent × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 4 Leukemia, Myeloid, Acute 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Uveal Melanoma 1 Thalassemia 1 Recurrence 1 Primary Immunodeficiency Diseases 1 Neoplasms, Plasma Cell 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hemoglobinopathies 1 Hematologic Neoplasms 1 Fanconi Anemia 1 Cytopenia 1 Anemia, Sickle Cell 1 Anemia, Diamond-Blackfan 1 Anemia, Aplastic 1 Anemia 1

Interventions

Cyclophosphamide 39 fludarabine phosphate 38 fludarabine 35 Imatinib Mesylate 33 Whole-Body Irradiation 31 Mycophenolic Acid 29 nilotinib 28 Tacrolimus 23 Busulfan 20 Cyclosporine 16 thymoglobulin 15 Melphalan 14 Granulocyte Colony-Stimulating Factor 14 Dasatinib 14 Antilymphocyte Serum 14 Thiotepa 12 Peripheral Blood Stem Cell Transplantation 12 Filgrastim 11 bosutinib 10 Stem Cell Transplantation 10 Methotrexate 10 ponatinib 8 Cord Blood Stem Cell Transplantation 8 sargramostim 7 Rituximab 7 Cytarabine 7 Cyclosporins 7 Clofarabine 6 plerixafor 5 Sirolimus 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡